Koutaïssoff, S <br/><br/>
Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Dec 1999 
 - 1151-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/s0360-3016(99)00307-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--mortality<br/>Adult<br/>Aged<br/>Carcinoma, Large Cell--mortality<br/>Carcinoma, Non-Small-Cell Lung--mortality<br/>Carcinoma, Squamous Cell--mortality<br/>Disease-Free Survival<br/>Dose Fractionation, Radiation<br/>Female<br/>Humans<br/>Lung Neoplasms--mortality<br/>Male<br/>Middle Aged<br/>Survival Rate<br/>Time Factors